series-b
Stage
1
Investors
About
KisoJi Biotechnology develops next-generation multi-specific antibody therapeutics targeting difficult oncology and other disease targets using proprietary single domain antibody platforms and AI-enabled technologies.
Explore KisoJi Biotechnology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.